Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

As U.S. employers grapple with trying to keep workers healthy and on the job amid fresh spikes in COVID-19 cases, CVS Health Corp has begun selling companies a diagnostic testing program.

CVS to offer companies COVID-19 testing program as U.S. cases rise

Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.

3 Investing Facts About Required Minimum Distributions You Need to Know - June 24, 2020

CVS to offer employers COVID-19 testing program as U.S. cases rise

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is CVS Health (CVS) Stock Undervalued Right Now?

Walgreens

Walmart

The big-box retailer continues to make moves into healthcare.

Why CVS and Walgreens Should Be Worried About Walmart

CVS Health: An Amazon-Proof Business On Sale

Cigna

UnitedHealth Group

U.S. health insurers may balk at covering tests that look for coronavirus antibodies in some cases, arguing that employers or the government should foot a bill expected to run into billions of dollars.

U.S. health insurers may balk at paying for coronavirus antibody testing

CHARLESTON, W.Va., June 15, 2020 /PRNewswire/ -- Aetna Better Health of West Virginia, a CVS Health company (NYSE: CVS), today announced that the West Virginia Department of Health and Human Resources (DHHR) has awarded the company a statewide Medicaid contract through the Mountain Health...

Aetna Better Health Announces Medicaid Contract Award in West Virginia

CVS Health’s stock (NYSE: CVS) has lost 15% of its value year-to-date, currently trading at levels of around $63. While the stock fell close to 30% to about $52 as the markets collapsed in March, it has risen by 21% from those lows.

Is CVS Health Oversold At $63?

Alexion Pharma

AT&T

Despite the big gains in recent months, not every stock is overpriced.

These 3 Value Stocks Are Absurdly Cheap  Right Now

Drugstore chain CVS Health Corp  joined Walmart Inc  in announcing it will stop keeping beauty and personal care products designed for people of color in locked display cases, after the practice drew criticism online.

CVS joins Walmart in keeping multicultural beauty products out of locked cabinets

Retailor Walgreens Boots Alliance Inc. (NYSE: WBA), drugstore chain CVS Health Corp (NYSE: CVS) and Walmart Inc.

CVS, Walgreens And Walmart Will No Longer Lock Up African American Beauty Products

Anthem

Castlight Health

Humana

iRobot

Teladoc

Zoom Video

The novel coronavirus exposed weaknesses in the healthcare system. These telehealth stocks are leading the effort to modernize healthcare.

7 Telehealth Stocks That Have Plenty of Growth On Tap

WOONSOCKET, R.I., June 11, 2020 /PRNewswire/ -- Building on the company's comprehensive efforts to help slow the spread of the virus, on Friday, June 12 CVS Health (NYSE: CVS) will open 10 new COVID-19 test sites at select CVS Pharmacy drive-thru locations across Kansas. These new sites...

CVS Health Opens 10 New Drive-Thru Test Sites in Kansas as Part of Nationwide COVID-19 Response

Telehealth is here to stay for the long haul, given the changes prompted by COVID-19.

Telehealth Poised for Long-Term Growth Post Coronavirus

Iron Mountain

Kellogg

Lowe's

Philip Morris

Public Storage

Raytheon Technologies

Xcel Energy

These nine boring stocks to buy won’t elicit much excitement from the crowd, but they’re worthy contenders as we head toward an uncertain future.

9 Boring Stocks to Buy You Should Never Let Go Of

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Why Is CVS Health (CVS) Up 8.3% Since Last Earnings Report?

And last month, the pharmacy giant started a test program that uses flying drones to deliver medicine to customers.

CVS Launches Pilot Program for Self-Driving Vehicles to Deliver Prescriptions

WOONSOCKET, R.I., June 1, 2020 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that Eva Boratto, Executive Vice President and Chief Financial Officer, and Karen Lynch, Executive Vice President and President of Aetna, will be participating in a fireside chat with...

CVS Health to Present at Goldman Sachs 41st Annual Global Healthcare Conference

Bank of New York Mellon

Home Depot

Checking out the out-of-favor sectors can reveal some hidden investing gems.

3 Embarrasingly Cheap Dividend Stocks

Target

Major retailers including Walmart, Target and CVS have closed stores as protests over the police killing of George Floyd turned violent, according to reports. Walmart, the nation’s largest retailer, shut hundreds of stores Sunday afternoon as protesters clashed with police and looting roiled some places.

George Floyd protests force Walmart, Target and CVS to close stores

Ping Identity Holding Corp

Your pocketbook will thank you if you hang onto these quality companies for the long term.

The Smartest Stocks to Invest $2,500 Into Right Now

Self-driving technology startup Nuro will start delivering prescriptions in June.

CVS Pharmacy prescriptions go high-tech with self-driving delivery

CVS Pharmacy plans to test delivering prescriptions using self-driving vehicles next month as part of a pilot program in Houston.

CVS Pharmacy partners with Nuro to test self-driving vehicle prescription delivery

CVS Health Thursday said it is delivering as promised to open 1,000 testing locations for the Coronavirus strain COVID-19.

News for CVS Health Stock (CVS)